SIA
EUCRU

Schechter Investment Advisors’s Eucrates Biomedical Acquisition Corp. Unit EUCRU Stock Holding History

Schechter Investment Advisors’s Portfolio EUCRU Stock Details EUCRU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-79,060
Closed -$792K – 968
2022
Q3 		$792K Buy
79,060
+2,418
+3% +$24.2K 0.08% 358
2022
Q2 		$759K Sell
76,642
-6,160
-7% -$61K 0.07% 376
2022
Q1 		$816K Sell
82,802
-4,590
-5% -$45.2K 0.08% 377
2021
Q4 		$872K Buy
+87,392
New +$872K 0.08% 351